Prasoon Madhukar

PhD graduate specializing in nanoparticle-based drug delivery, with expertise in formulation design, molecular diagnostics, cell and animal studies, and immunology. Experienced in developing innovative research strategies, managing cross-functional projects, and producing high-quality scientific documentation. Driven to advance biotechnology and therapeutic development through cutting-edge research. Seeking a role in biotech or pharma to apply expertise in translational research and drug development

• Nanomaterials Synthesis & Characterization, SATHI, BHU, 06/23
• Sophisticated R&D Equipment Training, SATHI BHU, 12/22
• RT-PCR & Next-Generation Sequencing Workshop, SERB, BHU, 11/23
• Diploma in Statistics & Computing, BHU, 01/22 - 10/22
• CeNSE DBT Nano-biotechnology Alliance (C-DNA) Familiarization workshop, IISc, Bangalore, 09/20
• International Webinar on Materials Synthesis and Characterization, Dr RML Awadh University and Florida Polytechnic University, 2020

• Best Poster Award, Advanced Materials for Better Tomorrow (AMBT), BHU, 10/23
• Best Poster Award, Recent Trends in Animal Sciences (RTAS), BHU, 2022
• Travel Grant Recipient, ESCMID Global 2024, Barcelona, Spain, 04/24
• Poster Presentation, International conference on Trends in Emerging Nanoscience, Institute of Nanoscience and Technology, Mohali, India, 11/23
• Outreach Grant Recipient, ECCMID, Copenhagen, Denmark, 04/23
• E-Poster Presentation, ASTMH Annual Meeting, Seattle, USA, 2022
• International Travel Support, SERB, Govt. of India, ICOPA, Copenhagen, Denmark, 08/22
• Poster Presentation, CIDSCON, Kolkata, India, 07/22

• English, Fluent
• Hindi, Fluent
• Bengali, Working Proficiency
• Spanish, Elementary proficiency

• CSIR-UGC: Junior Research Fellowship (JRF) & NET Eligibility, 2019
• ICMR: Junior Research Fellowship (JRF), 2019
• Graduate Aptitude Test in Engineering (GATE), Life Sciences, 2020

• Amine-Functionalized Graphene Quantum Dots Conjugated with Amphotericin B: Synthesis, Characterization, and In-Vitro Evaluation for Visceral Leishmaniasis Treatment., Madhukar P.; Kesarwani R.; Panday S.; Singh V.K.; Gedda M.R.; Shaz M.A.; Kumar R.; Sundar S., ACS Omega, Under Review, 2025
• Anti-leishmanial therapies: Overcoming current challenges with emerging therapies., Sundar S.; Madhukar P.; Kumar R., Expert Review of Anti-infective Therapy, 2024
• Dual Drug Delivery for Augmenting Bacterial Wound Complications via Tailored Ultradeformable Carriers., Arora, K.; Dhruw, B.; Pm, S.; Madhukar P.; Sundar, S.; Mudavath, S. L., Bioconjug Chem, 2024
• Evaluation of Blood Based Quantitative PCR as a Molecular Diagnostic Tool for Post Kala-Azar Dermal Leishmaniasis (PKDL)., Kumar, A.; Singh, V. K.; Madhukar P.; Tiwari, R.; Roy, R.; Rajneesh; Mehrotra, S.; Sundar, S.; Kumar, R., Mol Biol Rep, 2024
• Nanotechnology-Based Strategies in Parasitic Disease Management: From Prevention to Diagnosis and Treatment., Tiwari, R.; Gupta, R. P.; Singh, V. K.; Kumar, A.; Rajneesh, N.; Madhukar P.; Sundar, S.; Gautam, V.; Kumar, R., ACS Omega, 2023
• Post Kala-Azar Dermal Leishmaniasis in the Indian Sub-Continent: Challenges and Strategies for Elimination., Kumar, A.; Singh, V. K.; Tiwari, R.; Madhukar P.; Rajneesh; Kumar, S.; Gautam, V.; Engwerda, C.; Sundar, S.; Kumar, R., Front Immunol, 2023
• Ethyl Acetate Extract of Colletotrichum Gloeosporioides Promotes Cytotoxicity and Apoptosis in Human Breast Cancer Cells., Rai, N.; Gupta, P.; Verma, A.; Tiwari, R. K.; Madhukar P.; Kamble, S. C.; Kumar, A.; Kumar, R.; Singh, S. K.; Gautam, V., ACS Omega, 2022
• Nanodiagnostics in Leishmaniasis: A New Frontiers for Early Elimination., Gedda, M. R.; Madhukar P.; Shukla, A.; Mudavath, S. L.; Srivastava, O. N.; Singh, O. P.; Sundar, S., Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2021
• Post Kala-Azar Dermal Leishmaniasis: A Threat to Elimination Program., Gedda, M. R.; Madhukar P.; Singh, B.; Kumar, D.; Singh, A. K.; Upadhyay, S.; Singh, O. P.; Sundar, S., PLoS Neglected Tropical Diseases, 2020
• Evaluation of Safety and Antileishmanial Efficacy of Amine Functionalized Carbon-Based Composite Nanoparticle Appended With Amphotericin B: An in Vitro and Preclinical Study., Gedda, M. R.; Madhukar P. (Equal contribution); Vishwakarma, A. K.; Verma, V.; Kushwaha, A. K.; Yadagiri, G.; Mudavath, S. L.; Singh, O. P.; Srivastava, O. N.; Sundar, S., Front Chem, 2020
• Epigenetic Aspects of Engineered Nanomaterials: Is the Collateral Damage Inevitable?, Gedda, M. R.; Babele, P. K.; Zahra, K.; Madhukar P (Equal Contribution)., Frontiers in Bioengineering and Biotechnology, 2019
• Blood Biomarkers for Ischemic Stroke Subtype Differentiation: A Systematic Review., Pandey, S. P.; Madhukar P.; Dev, P.; Joshi, D.; Mishra, V. N.; Chaurasia, R. N.; Pathak, A., Cardiovascular & Hematological Disorders-Drug Targets, 2018

• Synthesis of Porous Silicon-based Nanoparticles., Madhukar, P.; Singh S.; Sundar S., Elsevier, 2025
• Characterization techniques for mesoporous silicon nanoparticles., Madhukar, P.; Murya P.; Kashyap S.; Sundar S., Elsevier, 2025
• Nanomedicine in Cardiovascular Diseases: Diagnostic and Therapeutic Innovations for Better Health., Madhukar, P.; Singh K.V.; Chauhan S.B.; Tiwari R.; Kumar A.; Rajneesh; Kumar R., Springer Nature, 2024
• MicroRNAs-Mediated Regulation of Immune Responses in Parasitic Infection., Roy, R.; Madhukar, P.; Singh, V. K.; Tiwari, R.; Kumar, A.; Rajneesh; Rai, M.; Gautam, V.; Sundar, S.; Kumar, R., MicroRNA in Human Infectious Diseases, 2024
• Post-Stroke Treatment Strategies, Management, and Rehabilitation: Where We Stand?, Gedda, M. R.; Pandey, S. P.; Zahra, K.; Madhukar, P.; Pathak, A., Advancement in the Pathophysiology of Cerebral Stroke, 2019